Our round-up of biotech financings is led this week by Braveheart Bio, a San Francisco biotech that has launched with $185 million, a lead drug for hypertrophic cardiomyopathy (HCM), and Biogen CEO ...
Podcasts Music Commentary Song of the Day From MPR News Music lovers from 89.3 The Current comb through mountains of music to choose the best new, independent, and unreleased songs to share with you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback